查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983868

血管內超音波市場：2026-2032年全球市場預測（依產品類型、血管內超音波模式、應用、最終用途及通路分類）

Intravascular Ultrasound Market by Product Type, IVUS Modalities, Application, End Use, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血管內超音波市場價值將達到 26.7 億美元，到 2026 年將成長至 28.4 億美元，到 2032 年將達到 42.4 億美元，複合年成長率為 6.85%。

主要市場統計數據
基準年 2025 26.7億美元
預計年份：2026年 28.4億美元
預測年份 2032 42.4億美元
複合年成長率 (%) 6.85%

對血管內超音波技術的發展和臨床應用進行基本概述，該技術影響著現代循環系統醫學中的決策和設備選擇。

血管內超音波（IVUS）已從單純的輔助診斷工具發展成為第一線影像技術，對介入治療策略和器械選擇產生重大影響。近年來，聲學陣列技術、高解析度成像模式以及導管設計的改進，縮小了血管內成像與即時手術指導之間的差距，使臨床醫生能夠更自信地觀察血管形態、量化斑塊負荷並最佳化器械尺寸。因此，IVUS在複雜的冠狀動脈和周邊血管介入治療中正發揮日益重要的作用，有助於提高手術精準度並可能改善臨床療效。

高解析度影像、軟體自動化和臨床證據的產生之間的變革性融合，正在重新定義血管內超音波在介入治療計劃中的作用。

血管內超音波（IVUS）的格局正因技術創新、不斷完善的臨床指南以及對術前結果的新期望而發生重塑。射頻陣列導管和改進的訊號處理演算法能夠更清晰地顯示斑塊成分和支架黏附情況，從而減少對透視影像推斷的依賴。同時，能夠自動提供管腔和斑塊測量數據的先進軟體套件，使得不同醫生能夠快速解讀影像並產生一致的報告，從而支援對標準化手術終點和結果進行比較分析。

評估 2025 年美國關稅變化如何促進血管內超音波(IVUS)相關人員的供應鏈重組、採購多元化和替代經營模式。

美國2025年實施的關稅調整和貿易政策變化，對醫療影像硬體和一次性醫療器材的採購、供應鏈和定價策略產生了複雜的影響。對於依賴精密設計的導管、客製化換能器材料和主機電子元件的血管內超音波（IVUS）而言，進口關稅的增加可能導致整體成本上升。為此，製造商正優先考慮區域採購多元化、關鍵零件的近岸生產以及設計改進，以減少對受關稅影響的原料的依賴，同時保持臨床性能。

基於細分的引人入勝的見解，將臨床應用、設備分類、最終使用環境以及在手術中的作用與可行的產品和商業化優先事項聯繫起來。

深入的細分分析揭示了臨床需求、產品設計和採購優先順序在應用、裝置類型、最終用途和治療目標方面的交匯點。將應用領域分類為冠狀動脈和周邊血管領域，並將冠狀動脈領域進一步細分為急性冠狀動脈症候群和慢性完全閉塞，將周邊血管領域細分為周邊動脈疾病和外周靜脈應用，結果表明，成像需求會因病變複雜程度、血管大小以及是否需要進行縱向血管評估而有所不同。這些臨床差異決定了產品團隊優先考慮的導管形狀、頻率選擇和影像處理功能。

美洲、歐洲、中東和非洲以及亞太地區的區域採用模式和戰略挑戰，這些都影響著臨床採用和商業化的路徑。

了解區域趨勢對於理解血管內超音波（IVUS）的應用模式和策略重點至關重要。在美洲，臨床上對介入性心臟病學創新的重視、針對複雜手術的完善報銷機制以及高病例醫療機構的集中，都促進了先進成像技術的應用和競爭激烈的服務市場。該地區的監管路徑和採購慣例強調可靠的臨床結果和成本效益論證，這影響供應商如何優先考慮臨床證據和上市後監測。

本報告闡述了競爭與合作的動態，展示了硬體領導者、細分市場創新者和軟體參與企業如何塑造血管內超音波(IVUS) 領域的產品差異化和市場定位。

血管內超音波（IVUS）領域的競爭動態持續利好那些能夠整合卓越硬體、軟體驅動的分析能力和強大的臨床支援的機構。老牌醫療設備製造商憑藉規模優勢、深厚的臨床關係和全球分銷網路保持領先地位，而專業成像領域的創新者則在圖像解析度、導管設計和工作流程整合方面展開競爭。新興參與企業（包括中小型科技公司和軟體開發人員）正挑戰傳統觀念，專注於機器學習驅動的斑塊分析、自動化報告和雲端資料管理，以支援多中心註冊研究和上市後證據收集。

為製造商和供應商提供具體的策略建議，以加速採用血管內超音波，協調證據產生、互通性、供應彈性和教育計畫。

血管內超音波（IVUS）生態系統中的領導企業需要協調其在臨床證據、產品互通性和供應鏈韌性方面的投資，以確保能夠掌握血管內影像技術日益成長的作用。首先，企業必須優先進行可操作的臨床研究，以明確血管內超音波何時能顯著改善手術效果，以及哪些指標對臨床醫師和支付者最為重要。此類證據應旨在支持有關指南納入和報銷的討論。其次，專注於開放標準以及與導管室系統、生理測量平台和電子健康記錄的互通性，將降低推廣應用的門檻，並支持收集長期數據以證明其價值。

綜合調查方法將臨床醫生和工程師的一手知識與二手文獻綜述和技術檢驗相結合，確保了嚴謹透明的分析。

本分析的研究基礎是將與介入性心臟病專家、血管專家、採購經理和器械工程師的初步定性訪談，與臨床文獻、監管指南和技術評估的嚴謹的二次研究相結合。初步資料包括旨在識別未滿足的臨床需求、手術流程和採購決策標準的結構化訪談和諮詢會議。除這些訪談外，還對導管設計、感測器架構和主機軟體功能進行了技術評估，並將產品的功能集和應用案例進行了匹配。

這篇摘要重點介紹了血管內超音波向不可或缺的圖像引導工具的轉變，以及將決定未來主導的策略行動。

血管內超音波正處於轉折點，技術成熟度、臨床需求和商業策略在此交匯融合，推動其在心血管和周邊血管介入治療中發揮越來越重要的作用。該技術能夠在手術過程中提供可操作的資訊，使其提案超越了單純的解剖成像，成為精準治療計劃和檢驗的基礎。隨著臨床指南和臨床醫生期望的不斷演變，能夠將產品創新與可操作的證據生成、全面的培訓和靈活的商業模式相結合的相關人員，將有機會引領該技術的普及應用。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：血管內超音波市場：依產品類型分類

  • IVUS導管
    • 陣列導管
    • 一體式導管
  • IVUS主機
    • 可攜式主機
    • 推車式主機

第9章：血管內超音波市場（依模式分類）

  • 虛擬組織學（VH）血管內超音波
  • iMAP IVUS
  • 整合反向散射（IB）血管內超音波

第10章 血管內超音波市場：依應用領域分類

  • 冠狀動脈
    • 急性冠狀動脈症候群
    • 慢性完全閉塞
  • 外圍
    • 周邊動脈疾病
    • 周邊靜脈輸液

第11章 血管內超音波市場：依最終用途分類

  • 門診手術中心
  • 醫院
  • 研究機構

第12章 血管內超音波市場：依分銷管道分類

  • 直銷
  • 透過分銷商銷售
  • 線上電子採購平台

第13章 血管內超音波市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 血管內超音波市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 血管內超音波市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國血管內超音波市場

第17章：中國血管內超音波市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • ACIST Medical Systems by Bracco SpA
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Conavi Medical Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE HealthCare Technologies Inc.
  • GERMITEC
  • Hologic, Inc.
  • Infraredx, Inc. by Nipro Company
  • Johnson & Johnson
  • Koninklijke Philips NV
  • Medtronic plc
  • Samsung Electronics Co., Ltd
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • Siemens AG
  • SonoScape Medical Corp.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-F6513A06BEE8

The Intravascular Ultrasound Market was valued at USD 2.67 billion in 2025 and is projected to grow to USD 2.84 billion in 2026, with a CAGR of 6.85%, reaching USD 4.24 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.67 billion
Estimated Year [2026] USD 2.84 billion
Forecast Year [2032] USD 4.24 billion
CAGR (%) 6.85%

Foundational overview of intravascular ultrasound developments and clinical integration shaping procedural decision-making and device selection in contemporary cardiovascular care

Intravascular ultrasound (IVUS) has evolved from an investigational adjunct to a frontline imaging modality that materially influences interventional strategy and device selection. Recent advances in acoustic array technology, higher-resolution imaging modes, and improved catheter designs have narrowed the gap between intravascular imaging and real-time procedural guidance, enabling clinicians to visualize vessel morphology, quantify plaque burden, and optimize device sizing with greater confidence. As a result, IVUS increasingly factors into complex coronary and peripheral interventions, supporting improved procedural precision and potentially better clinical outcomes.

Across care settings, adoption is driven by a combination of clinical evidence, operator training, and equipment accessibility. Technological synergies with complementary modalities, software-enabled analytics for automated measurements, and integration with cath lab workflows are shaping clinician expectations. Simultaneously, regulatory scrutiny and reimbursement pathways continue to influence procurement choices and deployment strategies. Taken together, these factors establish IVUS as both a clinical and commercial focal point for stakeholders seeking to differentiate through imaging-enabled value propositions.

Transformative convergence of higher-resolution imaging, software automation, and clinical evidence generation that is redefining the role of intravascular ultrasound in intervention planning

The IVUS landscape is being reshaped by a convergence of technology innovation, shifting clinical guidelines, and new expectations for procedural outcomes. High-frequency array catheters and improved signal processing algorithms now permit clearer delineation of plaque components and stent apposition, reducing reliance on fluoroscopic inference. Concurrently, enhanced software suites that provide automated lumen and plaque metrics are enabling faster interpretation and consistent reporting across operators, which supports standardized procedural endpoints and comparative outcomes analysis.

Moreover, procedural emphasis has migrated from purely anatomical success to functional and durability metrics, prompting clinicians to integrate IVUS findings with physiological assessments and intraprocedural decision-making. This shift encourages vendors to offer platforms that are interoperable with existing cath lab systems and that support data export for registries and longitudinal follow-up. In parallel, an ecosystem of partnerships between device manufacturers, software developers, and clinical centers is accelerating evidence generation and adoption. Taken together, these transformative shifts are redefining value propositions for IVUS across clinical, operational, and commercial dimensions.

Assessment of how 2025 United States tariff shifts have catalyzed supply chain realignment, sourcing diversification, and alternative commercial models for intravascular ultrasound stakeholders

Tariff adjustments and trade policy changes introduced in the United States in 2025 have exerted a complex influence on procurement, supply chains, and pricing strategies for medical imaging hardware and disposable devices. For IVUS, which relies on precision-engineered catheters, custom transducer materials, and console electronics, increased import duties can elevate landed costs. In response, manufacturers have prioritized regional sourcing diversification, nearshoring of key components, and redesigns that reduce dependency on tariff-affected inputs while preserving clinical performance.

Transitioning supply chains is not instantaneous; lead times for qualification, validation, and regulatory submission impose temporal friction. Consequently, healthcare providers have adopted staged purchasing strategies and longer-term service agreements to mitigate price volatility. At the same time, distributors and OEMs have explored alternative commercial models, including bundled service offerings and subscription-based access to consoles, to smooth revenue recognition and maintain customer relationships. From an innovation perspective, tariffs have incentivized investment in domestic manufacturing capacity and local assembly, which over time may strengthen supply resilience but also require careful capital planning and workforce development. Ultimately, the cumulative impact has been to accelerate strategic supply chain realignment while prompting more creative contracting approaches between providers and vendors.

Compelling segmentation-driven insights that link clinical applications, device typologies, end-use environments, and procedural roles to actionable product and commercialization priorities

Insightful segmentation analysis reveals where clinical demand, product design, and procurement priorities intersect across application, device type, end use, and procedural purpose. When applications are parsed into coronary and peripheral domains, with coronary further distinguished by acute coronary syndrome and chronic total occlusion and peripheral use differentiated into peripheral artery disease and peripheral venous applications, it becomes clear that imaging requirements diverge by lesion complexity, vessel size, and the need for longitudinal vessel assessment. These clinical distinctions drive catheter geometry, frequency selection, and image processing features that product teams prioritize.

Similarly, examining device type illuminates differing value chains and user workflows. Catheters split into array catheters and single element catheters reflect trade-offs between image fidelity, cost per use, and compatibility, while console segmentation into portable and stationary consoles highlights the demand for mobility in ambulatory and hybrid settings versus the capacity and performance expectations in hospital cath labs. End-use environments such as ambulatory surgical centers, hospitals, and research institutes each impose unique procurement cycles, capital approval processes, and integration requirements, which in turn influence decisions on capital expenditure versus disposable purchases. Finally, procedural segmentation into diagnostic and guidance functions-where diagnostic subcategories include lumen measurement and plaque characterization, and guidance subcategories include atherectomy support and stent placement-clarifies clinical workflows and evidence needs. Diagnostic applications emphasize quantitative reproducibility and reporting, while guidance applications demand real-time visualization, robust catheter handling, and integration with therapeutic devices. By synthesizing these axes of segmentation, companies can prioritize product features, clinical validation plans, and commercialization pathways aligned to specific clinical use cases and buyer profiles.

Regional adoption patterns and strategic imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence clinical uptake and commercialization pathways

Regional dynamics are critical to understanding adoption patterns and strategic priorities for IVUS. In the Americas, clinical emphasis on interventional cardiology innovation, well-established reimbursement frameworks for complex procedures, and a concentration of high-volume centers have supported advanced imaging adoption and a competitive service market. Regulatory pathways and procurement practices in the region place a premium on robust clinical outcomes and cost-effectiveness demonstrations, which influences how vendors prioritize clinical evidence and post-market surveillance.

In Europe, Middle East & Africa, the landscape is more heterogeneous, with marked variation in healthcare funding, access to advanced cath lab infrastructure, and local regulatory frameworks. This heterogeneity requires adaptive market entry strategies, partnerships with regional distributors, and flexible pricing approaches. In the Asia-Pacific region, rapid expansion of interventional capabilities, investment in domestic manufacturing, and growing clinical research activity are notable. Many health systems in that region are simultaneously building capacity in tertiary centers and broadening access through ambulatory settings, creating opportunities for both portable consoles and differentiated catheter designs. Across regions, differences in clinical practice patterns and procurement cycles necessitate tailored evidence generation and commercial models that reflect local payer expectations and operational realities.

Competitive and collaborative dynamics showing how hardware leaders, niche innovators, and software entrants are shaping product differentiation and market positioning in intravascular ultrasound

Competitive dynamics in the IVUS space continue to favor organizations that can integrate hardware excellence with software-enabled analytics and strong clinical support. Established medical device firms often leverage scale, deep clinical relationships, and global distribution networks to maintain leadership, while specialized imaging innovators compete on image resolution, catheter design, and workflow integration. Emerging entrants-including small-cap technology firms and software developers-are challenging conventions by focusing on machine learning-driven plaque analysis, automated reporting, and cloud-enabled data management that supports multicenter registries and post-market evidence collection.

Partnerships and strategic collaborations are increasingly important, whether through co-development agreements with therapeutic device manufacturers, licensing of advanced signal-processing algorithms, or consortium-based clinical studies that accelerate guideline inclusion. In addition, aftermarket services, training programs, and procedural decision-support tools have become differentiators that influence purchasing decisions. Successful companies balance investment in R&D with pragmatic commercialization strategies that prioritize interoperability, total cost of ownership considerations, and demonstrable clinical value delivered through improved procedural efficiency and patient outcomes.

Actionable strategic recommendations for manufacturers and providers to align evidence generation, interoperability, supply resilience, and education programs to accelerate intravascular ultrasound adoption

Leaders in the IVUS ecosystem should align investments across clinical evidence, product interoperability, and supply chain resilience to capture the expanding role of intravascular imaging. First, companies must prioritize pragmatic clinical studies that clarify when intravascular ultrasound materially improves procedural outcomes and which metrics matter most to operators and payers; such evidence should be designed to support guideline inclusion and reimbursement discussions. Second, focusing on open standards and interoperability with cath lab systems, physiologic measurement platforms, and electronic health records will lower barriers to adoption and support longitudinal data capture for value demonstration.

Operationally, vendors should diversify component sourcing, invest in regional manufacturing partnerships where feasible, and offer flexible commercial models that include service bundles, pay-per-use, or subscription options for consoles. Training and education remain critical; therefore, scalable programs that combine hands-on simulation, remote proctoring, and data-driven feedback loops will accelerate operator proficiency and adoption. Finally, executives should pursue targeted collaborations with therapeutic device manufacturers and software firms to co-create integrated solutions for guidance during atherectomy and stent placement, thereby strengthening clinical propositions and creating barrier-to-entry effects against less integrated competitors.

Comprehensive research methodology blending primary clinician and engineering insights with secondary literature review and technical validation to ensure rigorous, transparent analysis

The research underpinning this analysis synthesizes primary qualitative engagement with interventional cardiologists, vascular specialists, procurement leaders, and device engineers alongside rigorous secondary review of clinical literature, regulatory guidance, and technology assessments. Primary inputs included structured interviews and advisory discussions designed to uncover unmet clinical needs, procedural workflows, and procurement decision criteria. These conversations were complemented by technical assessments of catheter designs, transducer architectures, and console software capabilities to map product feature sets against clinical use cases.

Secondary research included peer-reviewed clinical studies, guideline statements, and regulatory documentation to validate clinical efficacy and safety considerations without extrapolating market volumes. Data triangulation techniques were applied to reconcile disparate inputs and surface consensus views, while limitations were clearly documented where evidence is emerging or heterogeneous. Throughout the process, methodological rigor was maintained through expert validation rounds, conflict-of-interest screening for interview participants, and adherence to ethical research standards for confidentiality and informed consent. This approach ensures that findings are grounded in contemporary clinical practice and technical feasibility while being transparent about areas that warrant further prospective study.

Concluding synthesis that highlights intravascular ultrasound's transition to an indispensable image-guided tool and the strategic actions that determine future leadership

Intravascular ultrasound stands at an inflection point where technological maturity, clinical expectations, and commercial strategy converge to expand its role in cardiovascular and peripheral interventions. The modality's capacity to provide actionable intraprocedural information has elevated its value proposition beyond anatomical imaging to a cornerstone of precision therapy planning and verification. As clinical guidelines and operator expectations evolve, stakeholders who align product innovation with pragmatic evidence generation, robust training, and flexible commercial models will be positioned to lead adoption curves.

Looking forward, the interplay of regional healthcare dynamics, supply chain adjustments, and software-driven analytics will determine which applications and device configurations gain the most traction. Strategic investments in interoperability and integrated procedural solutions will differentiate winners from followers, while partnerships that accelerate clinical validation and reimbursement pathways will unlock broader clinical utility. In sum, IVUS is transitioning from a specialized adjunct to an indispensable tool for interventionalists seeking reproducible, image-guided outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravascular Ultrasound Market, by Product Type

  • 8.1. IVUS Catheters
    • 8.1.1. Array Catheters
    • 8.1.2. Single Element Catheters
  • 8.2. IVUS Consoles
    • 8.2.1. Portable Consoles
    • 8.2.2. Cart-Based Consoles

9. Intravascular Ultrasound Market, by IVUS Modalities

  • 9.1. Virtual Histology (VH) IVUS
  • 9.2. iMAP IVUS
  • 9.3. Integrated Backscatter (IB) IVUS

10. Intravascular Ultrasound Market, by Application

  • 10.1. Coronary
    • 10.1.1. Acute Coronary Syndrome
    • 10.1.2. Chronic Total Occlusion
  • 10.2. Peripheral
    • 10.2.1. Peripheral Artery Disease
    • 10.2.2. Peripheral Venous Applications

11. Intravascular Ultrasound Market, by End Use

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Research Institutes

12. Intravascular Ultrasound Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributor Sales
  • 12.3. Online & E-Procurement Platforms

13. Intravascular Ultrasound Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intravascular Ultrasound Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intravascular Ultrasound Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intravascular Ultrasound Market

17. China Intravascular Ultrasound Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. ACIST Medical Systems by Bracco S.p.A.
  • 18.7. Avinger, Inc.
  • 18.8. B. Braun SE
  • 18.9. Boston Scientific Corporation
  • 18.10. Canon Medical Systems Corporation
  • 18.11. Conavi Medical Inc.
  • 18.12. Esaote S.p.A
  • 18.13. Fujifilm Corporation
  • 18.14. GE HealthCare Technologies Inc.
  • 18.15. GERMITEC
  • 18.16. Hologic, Inc.
  • 18.17. Infraredx, Inc. by Nipro Company
  • 18.18. Johnson & Johnson
  • 18.19. Koninklijke Philips N.V.
  • 18.20. Medtronic plc
  • 18.21. Samsung Electronics Co., Ltd
  • 18.22. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 18.23. Siemens AG
  • 18.24. SonoScape Medical Corp.
  • 18.25. Stryker Corporation
  • 18.26. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ARRAY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SINGLE ELEMENT CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PORTABLE CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CART-BASED CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY VIRTUAL HISTOLOGY (VH) IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IMAP IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY INTEGRATED BACKSCATTER (IB) IVUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL VENOUS APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY ONLINE & E-PROCUREMENT PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 169. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 170. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 171. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 173. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 175. GCC INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 200. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 201. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 203. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 204. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 205. G7 INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 209. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 210. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 211. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 213. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL INTRAVASCULAR ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS CONSOLES, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY IVUS MODALITIES, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY PERIPHERAL, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA INTRAVASCULAR ULTRASOUND MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)